{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:36:13Z","timestamp":1793050573692,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00198-026-08174-4","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T02:42:21Z","timestamp":1786416141000},"page":"2171-2183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and risk factors of bone fragility in duchenne muscular dystrophy: A systematic review and meta-analysis"],"prefix":"10.1007","volume":"37","author":[{"given":"Chuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyuhan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingkun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"issue":"3","key":"8174_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM et al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 17(3):251\u2013267","journal-title":"Lancet Neurol"},{"issue":"4","key":"8174_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM et al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 17(4):347\u2013361","journal-title":"Lancet Neurol"},{"issue":"Suppl 2","key":"8174_CR3","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1542\/peds.2018-0333E","volume":"142","author":"LM Ward","year":"2018","unstructured":"Ward LM, Hadjiyannakis S, McMillan HJ, Noritz G, Weber DR (2018) Bone health and osteoporosis management of the patient with Duchenne muscular dystrophy. Pediatrics 142(Suppl 2):S34\u2013S42","journal-title":"Pediatrics"},{"issue":"9","key":"8174_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00198-003-1443-y","volume":"14","author":"ML Bianchi","year":"2003","unstructured":"Bianchi ML, Mazzanti A, Galbiati E et al (2003) Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporos Int 14(9):761\u2013767","journal-title":"Osteoporos Int"},{"issue":"9","key":"8174_CR5","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0883073816650034","volume":"31","author":"N Perera","year":"2016","unstructured":"Perera N, Sampaio H, Woodhead H, Farrar M (2016) Fracture in Duchenne muscular dystrophy: natural history and vitamin D deficiency. J Child Neurol 31(9):1181\u20131187","journal-title":"J Child Neurol"},{"key":"8174_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejpn.2023.11.012","volume":"48","author":"S Specht","year":"2024","unstructured":"Specht S, Zhukova I, Westhoff JH et al (2024) Fat embolism syndrome in Duchenne muscular dystrophy: report on a novel case and systematic literature review. Eur J Paediatr Neurol 48:91\u2013100","journal-title":"Eur J Paediatr Neurol"},{"key":"8174_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"2","key":"8174_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jocd.2014.01.004","volume":"17","author":"N Bishop","year":"2013","unstructured":"Bishop N, Arundel P, Clark E et al (2013) Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 pediatric official positions. J Clin Densitom 17(2):275\u2013280","journal-title":"J Clin Densitom"},{"key":"8174_CR9","unstructured":"National Heart, Lung, and Blood Institute. Study quality assessment tools. Available at: https:\/\/www.nhlbi.nih.gov\/health-topics\/studyquality-assessment-tools. Accessed April 17, 2021"},{"issue":"1","key":"8174_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/01241398-200001000-00016","volume":"20","author":"CM Larson","year":"2000","unstructured":"Larson CM, Henderson RC (2000) Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop 20(1):71\u201374","journal-title":"J Pediatr Orthop"},{"issue":"2","key":"8174_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/01241398-200203000-00008","volume":"22","author":"LF Aparicio","year":"2002","unstructured":"Aparicio LF, Jurkovic M, DeLullo J (2002) Decreased bone density in ambulatory patients with Duchenne muscular dystrophy. J Pediatr Orthop 22(2):179\u2013181","journal-title":"J Pediatr Orthop"},{"issue":"10","key":"8174_CR12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1469-8749.2002.tb00272.x","volume":"44","author":"DG McDonald","year":"2002","unstructured":"McDonald DG, Kinali M, Gallagher AC et al (2002) Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol 44(10):695\u2013698","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"8174_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1177\/000992280304200408","volume":"42","author":"JE Bothwell","year":"2003","unstructured":"Bothwell JE, Gordon KE, Dooley JM, MacSween J, Cummings EA, Salisbury S (2003) Vertebral fractures in boys with Duchenne muscular dystrophy. Clin Pediatr (Phila) 42(4):353\u2013356","journal-title":"Clin Pediatr (Phila)"},{"key":"8174_CR14","doi-asserted-by":"crossref","unstructured":"Douvillez B, Braillon P, Hodgkinson I, Berard C (2005) Douleur, ost\u00e9op\u00e9nie et composition corporelle chez 22 patients atteints de dystrophie musculaire progressive de Duchenne. Etude descriptive [Pain, osteopenia and body composition of 22 patients with Duchenne muscular dystrophy: a descriptive study]. Ann Readapt Med Phys 48(8):616\u2013622","DOI":"10.1016\/j.annrmp.2005.03.011"},{"issue":"4","key":"8174_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nmd.2006.01.010","volume":"16","author":"WD Biggar","year":"2006","unstructured":"Biggar WD, Harris VA, Eliasoph L, Alman B (2006) Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscul Disord 16(4):249\u2013255","journal-title":"Neuromuscul Disord"},{"issue":"19","key":"8174_CR16","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1212\/01.wnl.0000260974.41514.83","volume":"68","author":"WM King","year":"2007","unstructured":"King WM, Ruttencutter R, Nagaraja HN et al (2007) Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurology 68(19):1607\u20131613","journal-title":"Neurology"},{"issue":"11\u201312","key":"8174_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.nmd.2007.05.008","volume":"17","author":"AC S\u00f6derpalm","year":"2007","unstructured":"S\u00f6derpalm AC, Magnusson P, Ahlander AC et al (2007) Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy. Neuromuscul Disord 17(11\u201312):919\u2013928","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"8174_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.pediatrneurol.2007.11.001","volume":"38","author":"S Houde","year":"2008","unstructured":"Houde S, Filiatrault M, Fournier A et al (2008) Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up. Pediatr Neurol 38(3):200\u2013206","journal-title":"Pediatr Neurol"},{"issue":"2","key":"8174_CR19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00198-010-1275-5","volume":"22","author":"ML Bianchi","year":"2011","unstructured":"Bianchi ML, Morandi L, Andreucci E, Vai S, Frasunkiewicz J, Cottafava R (2011) Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment. Osteoporos Int 22(2):529\u2013539","journal-title":"Osteoporos Int"},{"issue":"12","key":"8174_CR20","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.nmd.2012.06.354","volume":"22","author":"AL Mayo","year":"2012","unstructured":"Mayo AL, Craven BC, McAdam LC, Biggar WD (2012) Bone health in boys with Duchenne muscular dystrophy on long-term daily deflazacort therapy. Neuromuscul Disord 22(12):1040\u20131045","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"8174_CR21","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1651-2227.2011.02532.x","volume":"101","author":"AC S\u00f6derpalm","year":"2012","unstructured":"S\u00f6derpalm AC, Magnusson P, \u00c5hlander AC et al (2012) Bone mass development in patients with Duchenne and Becker muscular dystrophies: a 4-year clinical follow-up. Acta Paediatr 101(4):424\u2013432","journal-title":"Acta Paediatr"},{"issue":"4","key":"8174_CR22","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/mus.23948","volume":"49","author":"C Houston","year":"2014","unstructured":"Houston C, Mathews K, Shibli-Rahhal A (2014) Bone density and alendronate effects in Duchenne muscular dystrophy patients. Muscle Nerve 49(4):506\u2013511","journal-title":"Muscle Nerve"},{"issue":"4","key":"8174_CR23","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/mus.23963","volume":"49","author":"WM King","year":"2014","unstructured":"King WM, Kissel JT, Visy D, Goel PK, Matkovic V (2014) Skeletal health in Duchenne dystrophy: bone-size and subcranial dual-energy X-ray absorptiometry analyses. Muscle Nerve 49(4):512\u2013519","journal-title":"Muscle Nerve"},{"issue":"2","key":"8174_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00198-013-2442-2","volume":"25","author":"S Pouwels","year":"2014","unstructured":"Pouwels S, de Boer A, Leufkens HG et al (2014) Risk of fracture in patients with muscular dystrophies. Osteoporos Int 25(2):509\u2013518","journal-title":"Osteoporos Int"},{"issue":"6","key":"8174_CR25","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/BPO.0000000000000348","volume":"35","author":"KA James","year":"2015","unstructured":"James KA, Cunniff C, Apkon SD et al (2015) Risk factors for first fractures among males with Duchenne or Becker muscular dystrophy. J Pediatr Orthop 35(6):640\u2013644","journal-title":"J Pediatr Orthop"},{"issue":"4","key":"8174_CR26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s13760-015-0582-1","volume":"116","author":"AE Doulgeraki","year":"2016","unstructured":"Doulgeraki AE, Athanasopoulou HI, Katsalouli MS, Petrocheilou GM, Paspati IN, Monopolis IK (2016) Body composition of patients with Duchenne muscular dystrophy: the Greek experience. Acta Neurol Belg 116(4):565\u2013572","journal-title":"Acta Neurol Belg"},{"issue":"11","key":"8174_CR27","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.nmd.2016.08.011","volume":"26","author":"C Tian","year":"2016","unstructured":"Tian C, Wong BL, Hornung L et al (2016) Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy. Neuromuscul Disord 26(11):760\u2013767","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"8174_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00198-016-3774-5","volume":"28","author":"J Ma","year":"2017","unstructured":"Ma J, McMillan HJ, Karag\u00fczel G et al (2017) The time to and determinants of first fractures in boys with Duchenne muscular dystrophy. Osteoporos Int 28(2):597\u2013608","journal-title":"Osteoporos Int"},{"key":"8174_CR29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jpeds.2016.11.078","volume":"182","author":"BL Wong","year":"2017","unstructured":"Wong BL, Rybalsky I, Shellenbarger KC et al (2017) Long-term outcome of interdisciplinary management of patients with Duchenne muscular dystrophy receiving daily glucocorticoid treatment. J Pediatr 182:296-303.e1","journal-title":"J Pediatr"},{"issue":"1","key":"8174_CR30","first-page":"77","volume":"12","author":"M Barzegar","year":"2018","unstructured":"Barzegar M, Niknam E, Habibi P, Shiva S, Tahmasebi S (2018) Bone mineral density and bone metabolism in patients with Duchenne muscular dystrophy. Iran J Child Neurol 12(1):77\u201383","journal-title":"Iran J Child Neurol"},{"key":"8174_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bone.2018.07.019","volume":"116","author":"NJ Crabtree","year":"2018","unstructured":"Crabtree NJ, Adams JE, Padidela R et al (2018) Growth, bone health & ambulatory status of boys with DMD treated with daily vs. intermittent oral glucocorticoid regimen. Bone 116:181\u2013186","journal-title":"Bone"},{"issue":"4","key":"8174_CR32","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3233\/JND-180317","volume":"5","author":"DR Weber","year":"2018","unstructured":"Weber DR, Thomas S, Erickson SW et al (2018) Bone health and endocrine care of boys with Duchenne muscular dystrophy: data from the MD STARnet. J Neuromuscul Dis 5(4):497\u2013507","journal-title":"J Neuromuscul Dis"},{"issue":"6","key":"8174_CR33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/BPO.0000000000000817","volume":"38","author":"A Singh","year":"2018","unstructured":"Singh A, Schaeffer EK, Reilly CW (2018) Vertebral Fractures in Duchenne muscular dystrophy patients managed with deflazacort. J Pediatr Orthop 38(6):320\u2013324","journal-title":"J Pediatr Orthop"},{"issue":"4","key":"8174_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/mus.26416","volume":"59","author":"C-G Del Roc\u00edo","year":"2019","unstructured":"Del Roc\u00edo C-G, Rodr\u00edguez-Cruz M, Almeida-Becerril T, Maldonado-Hern\u00e1ndez J, Baeza CW (2019) Muscle function and age are associated with loss of bone mineral density in Duchenne muscular dystrophy. Muscle Nerve 59(4):417\u2013421","journal-title":"Muscle Nerve"},{"issue":"6","key":"8174_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/jamaneurol.2019.0242","volume":"76","author":"S Joseph","year":"2019","unstructured":"Joseph S, Wang C, Bushby K et al (2019) Fractures and linear growth in a nationwide cohort of boys with Duchenne Muscular dystrophy with and without glucocorticoid treatment: results from the UK NorthStar Database. JAMA Neurol 76(6):701\u2013709","journal-title":"JAMA Neurol"},{"issue":"1","key":"8174_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.nmd.2018.09.005","volume":"29","author":"S Joseph","year":"2019","unstructured":"Joseph S, Wang C, Di Marco M et al (2019) Fractures and bone health monitoring in boys with Duchenne muscular dystrophy managed within the Scottish Muscle Network. Neuromuscul Disord 29(1):59\u201366","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"8174_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00431-019-03336-5","volume":"178","author":"KT Kao","year":"2019","unstructured":"Kao KT, Joseph S, Capaldi N et al (2019) Skeletal disproportion in glucocorticoid-treated boys with Duchenne muscular dystrophy. Eur J Pediatr 178(5):633\u2013640","journal-title":"Eur J Pediatr"},{"issue":"3","key":"8174_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5606\/tftrd.2019.3565","volume":"65","author":"FM Sertpoyraz","year":"2019","unstructured":"Sertpoyraz FM, Tiftik\u00e7io\u011flu B\u0130 (2019) The relationship of bone mineral density and vitamin D levels with steroid use and ambulation in patients with Duchenne muscular dystrophy. Turk J Phys Med Rehabil 65(3):216\u2013221","journal-title":"Turk J Phys Med Rehabil"},{"issue":"9","key":"8174_CR39","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/PHM.0000000000001423","volume":"99","author":"S Yildiz","year":"2020","unstructured":"Yildiz S, Glanzman AM, Estilow T et al (2020) Retrospective analysis of fractures and factors causing ambulation loss after lower limb fractures in Duchenne muscular dystrophy. Am J Phys Med Rehabil 99(9):789\u2013794","journal-title":"Am J Phys Med Rehabil"},{"issue":"5","key":"8174_CR40","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1515\/jpem-2020-0680","volume":"34","author":"R Suthar","year":"2021","unstructured":"Suthar R, Reddy BVC, Malviya M et al (2021) Bone density and bone health alteration in boys with Duchenne muscular dystrophy: a prospective observational study. J Pediatr Endocrinol Metab 34(5):573\u2013581","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"8174_CR41","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s40618-021-01676-4","volume":"45","author":"A Catalano","year":"2022","unstructured":"Catalano A, Vita GL, Bellone F et al (2022) Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates. J Endocrinol Invest 45(3):517\u2013525","journal-title":"J Endocrinol Invest"},{"key":"8174_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.860413","volume":"13","author":"C Liu","year":"2022","unstructured":"Liu C, Yang DD, Zhang L et al (2022) Bone mineral density assessment by quantitative computed tomography in glucocorticoid-treated boys with Duchenne muscular dystrophy: a linear mixed-effects modeling approach. Front Endocrinol (Lausanne) 13:860413","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"8174_CR43","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00198-022-06416-9","volume":"33","author":"K Tsaknakis","year":"2022","unstructured":"Tsaknakis K, J\u00e4ckle K, L\u00fcders KA, Lorenz HM, Braunschweig L, Hell AK (2022) Reduced bone mineral density in adolescents with Duchenne muscular dystrophy (DMD) and scoliosis. Osteoporos Int 33(9):2011\u20132018","journal-title":"Osteoporos Int"},{"issue":"6","key":"8174_CR44","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/mus.27762","volume":"67","author":"J Liaw","year":"2023","unstructured":"Liaw J, Billich N, Carroll K et al (2023) Fracture risk and impact in boys with Duchenne muscular dystrophy: a retrospective cohort study. Muscle Nerve 67(6):489\u2013496","journal-title":"Muscle Nerve"},{"issue":"1","key":"8174_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00198-022-06578-6","volume":"34","author":"K Phung","year":"2023","unstructured":"Phung K, McAdam L, Ma J et al (2023) Risk factors associated with prevalent vertebral fractures in Duchenne muscular dystrophy. Osteoporos Int 34(1):147\u2013160","journal-title":"Osteoporos Int"},{"issue":"2","key":"8174_CR46","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1210\/clinem\/dgad435","volume":"109","author":"K Phung","year":"2024","unstructured":"Phung K, McAdam L, Ma J et al (2024) Risk factors associated with incident vertebral fractures in steroid-treated males with Duchenne muscular dystrophy. J Clin Endocrinol Metab 109(2):536\u2013548","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"8174_CR47","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00198-024-07018-3","volume":"35","author":"L Zhou","year":"2024","unstructured":"Zhou L, Zhou H, Xu H et al (2024) Different bone health progression patterns and early-stage risk marker in glucocorticoid-treated ambulatory Duchenne muscular dystrophy. Osteoporos Int 35(6):997\u20131005","journal-title":"Osteoporos Int"},{"issue":"2","key":"8174_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/mus.28309","volume":"71","author":"C Panicucci","year":"2025","unstructured":"Panicucci C, Casalini S, Angelelli A et al (2025) Bone health determinants in ambulant prepubertal boys with Duchenne muscular dystrophy treated with deflazacort: findings from a 3-year study. Muscle Nerve 71(2):191\u2013199","journal-title":"Muscle Nerve"},{"issue":"1","key":"8174_CR49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1055\/a-2417-0441","volume":"56","author":"K Prasiw","year":"2025","unstructured":"Prasiw K, Khongkhatithum C, Fuangfa P, Kositwattanarerk A, Mahachoklertwattana P, Poomthavorn P (2025) Frequent unrecognized vertebral fractures associated with increased body fat mass in children and adolescents with Duchenne muscular dystrophy. Neuropediatrics 56(1):12\u201319","journal-title":"Neuropediatrics"},{"issue":"1","key":"8174_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0316938","volume":"20","author":"B Wang","year":"2025","unstructured":"Wang B, Zhou L, Li S et al (2025) Height development and multiple bone health indicators in children aged 2\u201312 years with Duchenne muscular dystrophy (DMD). PLoS ONE 20(1):e0316938","journal-title":"PLoS ONE"},{"issue":"3","key":"8174_CR51","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/jbmr.4187","volume":"36","author":"X Cheng","year":"2021","unstructured":"Cheng X, Zhao K, Zha X et al (2021) Opportunistic screening using low-dose CT and the prevalence of osteoporosis in China: a nationwide. Multicenter study. J Bone Miner Res 36(3):427\u2013435","journal-title":"J Bone Miner Res"},{"issue":"4","key":"8174_CR52","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s00774-020-01196-w","volume":"39","author":"JY Tung","year":"2021","unstructured":"Tung JY, Lam TP, Chan SH (2021) Bone microarchitectural alterations in boys with Duchenne muscular dystrophy on long-term glucocorticoid treatment. J Bone Miner Metab 39(4):606\u2013611","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"8174_CR53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ et al (2010) Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 9(2):177\u2013189","journal-title":"Lancet Neurol"},{"issue":"15","key":"8174_CR54","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1001\/jama.2022.4315","volume":"327","author":"M Guglieri","year":"2022","unstructured":"Guglieri M, Bushby K, McDermott MP et al (2022) Effect of different corticosteroid dosing regimens on clinical outcomes in boys with Duchenne muscular dystrophy: a randomized clinical trial. JAMA 327(15):1456\u20131468","journal-title":"JAMA"},{"issue":"10","key":"8174_CR55","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/jamaneurol.2022.2480","volume":"79","author":"M Guglieri","year":"2022","unstructured":"Guglieri M, Clemens PR, Perlman SJ et al (2022) Efficacy and safety of vamorolone vs placebo and prednisone among boys with Duchenne muscular dystrophy: a randomized clinical trial. JAMA Neurol 79(10):1005\u20131014","journal-title":"JAMA Neurol"},{"issue":"3","key":"8174_CR56","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1097\/MS9.0000000000003049","volume":"87","author":"E Zulfiqar","year":"2025","unstructured":"Zulfiqar E, Hurjkaliani S, Umar SA et al (2025) Comparing intermittent and daily prednisone in Duchenne muscular dystrophy: a systematic review and meta-analysis. Ann Med Surg 87(3):1637\u20131645","journal-title":"Ann Med Surg"},{"issue":"2","key":"8174_CR57","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207948","volume":"102","author":"E Landfeldt","year":"2024","unstructured":"Landfeldt E, Phung K, Zaman F et al (2024) Bisphosphonates in glucocorticoid-treated patients with Duchenne muscular dystrophy: a systematic review and grading of the evidence. Neurology 102(2):e207948","journal-title":"Neurology"},{"issue":"11","key":"8174_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10685","volume":"6","author":"ML Bianchi","year":"2022","unstructured":"Bianchi ML, Vai S, Baranello G et al (2022) Low-intensity vibration protects the weight-bearing skeleton and suppresses fracture incidence in boys with Duchenne muscular dystrophy: A prospective, randomized, double-blind, placebo-controlled clinical trial. JBMR Plus 6(11):e10685","journal-title":"JBMR Plus"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08174-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08174-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08174-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:02:32Z","timestamp":1793048552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08174-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["8174"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-08174-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"10 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}